Clinical Trials Logo

Hypersensitivity clinical trials

View clinical trials related to Hypersensitivity.

Filter by:

NCT ID: NCT01837251 Completed - Clinical trials for Recurrent Platinum-sensitive Ovarian Cancer

Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer

Start date: May 2013
Phase: Phase 3
Study type: Interventional

Evaluation of the best therapeutic index for patients with platinum-sensitive ovarian cancer when treatment with bevacizumab and gemcitabine/carboplatin or with bevacizumab and PLD/carboplatin.

NCT ID: NCT01834352 Withdrawn - Clinical trials for Nut Hypersensitivities

Walnut Oral Immunotherapy for Tree Nut Allergy

WOIT
Start date: November 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if walnut oral immunotherapy can be used in subjects allergic to tree nuts to decrease their tree nut allergy and induce changes in their immune system.

NCT ID: NCT01832324 Enrolling by invitation - Clinical trials for Eosinophilic Esophagitis

Molecular Basis of Food Allergy

Start date: January 2011
Phase:
Study type: Observational

The Study examines the molecular basis of food allergy. It explores the interaction between T cells, InKT cells and cytokines in the development of food allergy. The study also explores these factors in development of tolerance "outgrowing" food allergy. It will also explore the genetic factors that lead to the development of food allergy. The study examines all type of food allergy including IgE mediated reactions, Eosinophilic Esophagitis and Food Protein Induced Enterocolitis

NCT ID: NCT01831817 Completed - Clinical trials for Dentinal Hypersensitivity

Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity

Start date: January 2013
Phase: Phase 2
Study type: Interventional

The purpose of this exploratory study is to compare the treatment effect on dentinal hypersensitivity of a tubule occluding dentifrice as measured by Schiff and Tactile sensitivity. This proof of concept study will compare the test dentifrice with three other treatment groups.

NCT ID: NCT01830673 Completed - Clinical trials for Grass Pollen Allergy

Regulatory T-cells After Subcutaneous Immunotherapy

RTCAS
Start date: October 2011
Phase: N/A
Study type: Observational

The primary endpoint was the induction of T-regulatory cells under s specific subcutaneous immunotherapy (SCIT). Patients suffering from grass pollen allergy (relevant clinical symptomes during the pollen season, Skin Prick test diamter >4mm or RAST class II or higher) were included. The patients were allocated to three study groups: Group 1: during and directly after SCIT (after completion the 2nd or 3rd year of treatment) Group 2: completed SCIT more then three years ago Group 3: Patients with clinically relevant grass pollen allergy without SCIT. The investigators analyzed the lung function parameters, exhaled NO (eNO) and asked the patients to record symptoms during the adjacent pollen season. A blood sample was drawn to analyze the amount of TH1 and TH2 and regulatory T-cells, inflammatory markers(IL-2, IL-5, IL-10, IL-12/23, TNF-alpha, IFN-gamma) and blocking antibodies (IgG, IgG4).

NCT ID: NCT01827670 Completed - Clinical trials for Dentine Hypersensitivity

Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity

Start date: February 2013
Phase: Phase 3
Study type: Interventional

Clinical studies have demonstrated long term relief from dentine hypersensitivity with twice daily brushing of a toothpaste containing stannous fluoride in comparison to marketed (negative) controls. The aim of this study is to evaluate the effectiveness of a stannous fluoride dentifrice in the treatment of dentinal hypersensitivity compared to a marketed (negative) control, over a period of 56 days (8 weeks) with twice daily brushing.

NCT ID: NCT01822353 Completed - Food Allergy Clinical Trials

The Effect of Per Oral Immunotherapy in Severe IgE Mediated Egg, Milk, and Nut Allergy in Adults

Start date: January 2013
Phase: N/A
Study type: Interventional

In Finland, the estimated prevalence of physician-diagnosed food allergy in 1-4 year old children is 9%, and the most common allergen is milk. The overall food allergy has been reported to be 3.7%. Hen's egg allergy is among the most common food allergies in childhood. In addition, it predicts later development of allergic disease such as asthma. Most of the egg and milk allergy is transient and disappears in childhood. Currently, the standard of care for food allergy includes strict allergen avoidance. However, oral immunotherapy has been under investigation in children milk, egg, and wheat allergy. Previously, induction of clinical egg tolerance has been reported with egg oral immunotherapy in children aged from 3 to 13 years. In adults, strict avoidance is still the standard care but there is also growing interest in treatment of severe food allergy with oral immunotherapy or anti-IgE. The investigators aim to analyse the results of per oral immunotherapy treatment in severe IgE-mediated egg, milk, and nut allergy in adults. Could severe egg, milk and nut allergy be treated with oral immunotherapy treatment in stead of total allergen avoidance and could desensitization thus be achieved?

NCT ID: NCT01816542 Not yet recruiting - Allergy Clinical Trials

Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests

Start date: June 2013
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if any of Mother's Choice' all-natural personal-care products cause either irritation or allergic reaction when applied to both normal or sensitive skin. Each product will be tested on the skin using patch tests.

NCT ID: NCT01814241 Completed - Clinical trials for Food Hypersensitivity

Mechanisms of Desensitization During Peanut Oral Immunotherapy

PnOIT4
Start date: April 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to attempt to understand how desensitization works in peanut allergic children who are undergoing oral immunotherapy (OIT) to peanut. We want to identify the early changes in the desensitization process the immune cells undergo to become desensitized to the peanut protein.

NCT ID: NCT01809951 Completed - Cow's Milk Allergy Clinical Trials

Isomil Post Marketing Observational Study

Start date: August 2011
Phase: N/A
Study type: Observational

The use of soy-isolate protein based formula for infants with cow's milk protein intolerance is common in Indonesia, however, there has not been any systematic collection of clinical data to determine the formula's gastrointestinal tolerance, and the parent's perceptions regarding the formula.